BUZZ - Insmed shares fall as CFO Sara Bonstein resigns
路透社2026/10/05 11:46October 5 - ** Shares of pharmaceutical company Insmed (INSM.O) fell more than 3% in pre-market trading to $107.59. ** Sara Bonstein will resign from her position as Chief Financial Officer, effective October 30. ** Sara will stay on until the end of this month to ensure a smooth transition during the company's release of its Q3 financial results on October 29. ** Before joining Insmed, Sara served as Chief Financial Officer at OncoSec Medical. ** The company reaffirmed its fiscal 2026 performance guidance and has begun the search for the next Chief Financial Officer. ** All 25 brokerages covering the stock remain bullish; the median target price is compiled by LSEG data. ** As of the close of the previous trading day, the stock was down 36.15% year-to-date. (To assist non-English speakers, Reuters automatically translates its reports into several other languages. Because automated translations may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of the translated text and provides automated translation solely for reader convenience. Reuters accepts no liability for any damage or losses caused by the use of automated translation functionality.)
October 5 - ** The share price of pharmaceutical company Insmed (INSM.O) fell more than 3% in pre-market trading to $107.59
** Sara Bonstein will resign as Chief Financial Officer, effective October 30
** Sara will remain until the end of this month to ensure a smooth transition during the company's third quarter earnings release on October 29
** Prior to joining Insmed, Sara served as Chief Financial Officer of OncoSec Medical
** The company reaffirmed its fiscal year 2026 guidance and has begun the search for the next Chief Financial Officer
** All 25 brokerages covering the stock are bullish; the median target price — data compiled by LSEG
** As of the close of the last trading day, the stock was down 36.15% year-to-date
(To facilitate non-native English speakers, Reuters has automated the translation of its reports into several other languages. Because automated translation may contain errors or may lack necessary context, Reuters does not guarantee the accuracy of the automated translation text and provides it solely for the convenience of readers. Reuters assumes no liability for any damage or loss caused by the use of the automated translation function.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The New Zealand Dollar edges off its low as the US Dollar slips
Encompass Health Opens Rehabilitation Hospital in Bangor, Maine
05:57 PM EDT, 10/06/2026 (MT Newswires) -- Encompass Health (EHC) said late Tuesday it has opened the Encompass Health Rehabilitation Hospital of Bangor in Bangor, Maine and the 50-bed inpatient rehabilitation hospital is now accepting patients. The hospital offers essential rehabilitation services to help patients recovering from strokes, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions regain functional ability, independence and quality of life, the company said. Patients receive physical, occupational and speech therapy based on their individual needs.
Constellation Brands, the maker of Corona beer, exceeds market expectations in the second quarter thanks to strong demand
Reuters, October 6 - Constellation Brands (STZ.N) reported on Tuesday that its second-quarter profit and sales both exceeded market expectations, thanks to strong demand for its beer products such as Modelo Especial and Victoria, which effectively offset challenges facing the alcohol sector amid weak consumer sentiment. The company also announced that it had acquired SpikedAde, a ready-to-drink (RTD) company with vodka-based products, for at least $75 million, as part of its strategy to expand into new demand segments and strengthen its position in the fast-growing RTD category. Constellation Brands will pay $75 million upon the closing of the SpikedAde deal, and up to an additional $278 million over the next five years, depending on the brand’s performance and the company’s capital allocation priorities. The company’s beer business benefited this year from major sports events, as the FIFA World Cup and NBA Finals boosted viewing parties and social drinking occasions. According to data compiled by London Stock Exchange Group (LSEG), net sales for the quarter ended August 31 rose 6% to $2.63 billion, surpassing analysts’ average estimate of $2.54 billion. Adjusted earnings per share for the quarter were $3.74, above the expected $3.56. The wine and spirits business reported quarterly net sales growth of 17%, while beer increased by 5%. Constellation Brands reaffirmed its fiscal 2027 performance outlook: adjusted earnings per share between $11.20 and $11.90, with organic net sales expected to range from a 1% decline to a 1% increase. The company lowered its annual operating margin forecast from the previous 32%-33% range to between 31% and 32%. Its stock fell 4.5% in after-hours trading, with a year-to-date drop of about 16%. In April, the company withdrew its fiscal 2028 performance outlook, citing a turbulent operating environment and uncertain near-term prospects.
Kraft Heinz General Counsel Angel S. Willis resigns effective Oct. 20
Kraft Heinz EVP, Global General Counsel and Corporate Affairs Officer Angel S. Willis will resign effective Oct. 20, 2026. Willis notified the company on Oct. 2, 2026, citing plans to pursue other opportunities. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Kraft Heinz Company published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001637459-26-000067), on October 06, 2026, and is solely responsible for the information contained therein.